Three more I-Mab execs exit after US/China operations split
As I-Mab Biopharma embarks on its next chapter as a fully US-based company, it’s parting ways with more executives from the old era.
Chief Business …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
